Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
autoimmune diseases
2
×
biotech
biotech ipos
boston blog main
boston top stories
clinical trials
immunotherapy
investing
life sciences
medicare
2
×
national
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
abeona therapeutics
accent therapeutics
achilles therapeutics
acute myeloid leukemia
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alnylam pharmaceuticals
alopecia areata
alx oncology
amarin
amgen
aridis pharmaceuticals
aristea therapeutics
axitinib
bellus health
berkeley lights
bolt biotherapeutics
boulder/denver blog main
boulder/denver top stories
bridgebio
bristol-myers squibb
cancer
What
market
2
×
new
advantages
arrival
bar
bio
biotech
brings
companies
days
drug
expect
gamble
hasn’t
industry
ipo
ipos
life
medco’s
momentum
mover
patients
payers
physicians
plan
pricing
raised
research
roundup
science
sets
slowed
street
summer’s
type
ubiome
undone
vertex’s
wall
week
Language
unset
Current search:
market
×
medicare
×
" autoimmune diseases "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone